NASDAQ · Financial Statements
Palvella Therapeutics, Inc. (PVLA) Financial Statements
$138.77
NASDAQ: PVLA
Market Cap $1.99B
Overview Financials Dividend Palvella Therapeutics, Inc. most recently reported annual revenue of $0, net profit of $-42.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $31.0M $26.0M $0 $0 $0 Operating Profit $-52.0M $-43.0M $-12.0M $-14.0M $-39.0M Net Profit $-46.0M $-33.0M $19.0M $-17.0M $-42.0M EPS $-56.69 $-29.61 $14.74 $-7.83 $-3.71 Op Margin -165.0% -167.8% — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $154.0M $17.0M $8.0M $88.0M $60.0M Total Liabilities $103.0M $40.0M $11.0M $26.0M $32.0M Cash $118.0M $16.0M $7.0M $84.0M $58.0M Borrowings $15.0M $0 $0 $0 $1.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-8.0M $-15.0M $-14.0M $-11.0M $-25.0M Investing Cash Flow $-2.0M $0 $0 $0 $0 Financing Cash Flow $0 $0 $5.0M $9.0M $-1.0M Net Cash Flow $47.0M $-5.0M $-31.0M $76.0M $-26.0M Free Cash Flow $-9.0M $-15.0M $-14.0M $-11.0M $-25.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.98 EV / EBITDA -35.82 FCF Yield -1.85% Quick Ratio 21.18 Interest Coverage -7.60 Return 1Y 272.94% Return 3Y 678.91% Return 5Y -46.84%
Screens featuring this stock